 వతెివ్లెనివ్దిదిందింది. బిరంరుంవితుంయింది. బిపెరిందింది. brutality�ెబారిసౕరియుంది. వ్ముషన్తు. కథతైతిసందది. మనిసారాంనూది. మనింది� if we can identify a host protein in human body that can resist or that can control the MTB infection or tuberculosis infection. So from last six years we are working specifically on this project and what we found that during this TB infection there is decrease of this protein and when this protein goes down the bacteria grows easily in the cells. So we found if we can somehow control this protein level in the cells then this bacterial infection can go down. So that's why we are saying that this host protein is a very important protein for controlling the TB infection and if the level of this protein can be regulated we can target the TB infection. So that's why now we have this target which can be used to look into as a host directed therapy. We call it host directed therapy because most of the therapies are for killing the bacteria. But here we are not killing the bacteria, we are increasing the power of our cells so that they can themselves kill the bacteria.